Tocilizumab Pre-Treatment Significantly Reduces The Incidence Of Cytokine Release Syndrome In Patients With Relapsed/Refractory Multiple Myeloma (Rrmm) Who Receive Cevostamab
Cevostamab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Tocilizumab Pre-Treatment Significantly Reduces The Incidence Of Cytokine Release Syndrome In Patients With Relapsed/Refractory Multiple Myeloma (Rrmm) Who Receive Cevostamab ### Output: Cevostamab